Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2023
Filter by date:
Showing 1262 press releases before 2023
-
AstraZeneca Terminates License Agreement with MAP Pharmaceuticals Regarding Unit Dose Budesonide
-
AstraZeneca to Advance AZD3480 in ADHD
-
IRESSA (Gefitinib) Receives Marketing Authorisation for the Treatment of Non-Small Cell Lung Cancer in Europe
-
AstraZeneca Development Partner, Pozen, Inc., Submits New Drug Application for PN400
AstraZeneca Development Partner, Pozen, Inc., Submits New Drug Application for PN400
-
ONGLYZA (saxagliptin) Receives Positive Opinion in Europe for the Treatment of Type 2 Diabetes
-
Favourable Vote from FDA Advisory Committee on Seroquel Paediatric Supplemental New Drug Applications
-
AstraZeneca and Abbott Extend Relationship to Include Co-Promotion of Trilipix
-
AstraZeneca and Abbott Submit New Drug Application to the FDA for the Approval of CERTRIAD for the Treatment of Mixed Dyslipidemia
-
AstraZeneca and Merck & Co., Inc. Form Pioneering Collaboration to Investigate Novel Combination Anticancer Regimen
-
AstraZeneca Regulatory Update on Seroquel XR for the Treatment of Major Depressive Disorder
Latest articles and press releases
All of our latest press releases and articles are available to explore
Use a maximum of two downloads here
